Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 1
2012 2
2013 3
2014 4
2015 5
2016 2
2017 2
2018 3
2019 4
2020 10
2021 7
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.
Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J, Peeters M, Findlay M, Weaver A, Mills J, Wilson C, Adams R, Francis A, Moschandreas J, Virdee PS, Dutton P, Love S, Gebski V, Gray A; FOXFIRE trial investigators; SIRFLOX trial investigators; FOXFIRE-Global trial investigators; van Hazel G, Sharma RA. Wasan HS, et al. Lancet Oncol. 2017 Sep;18(9):1159-1171. doi: 10.1016/S1470-2045(17)30457-6. Epub 2017 Aug 3. Lancet Oncol. 2017. PMID: 28781171 Free PMC article. Clinical Trial.
Treatment compliance in early-stage anal cancer.
Pretta A, Trevisi E, Bregni G, Deleporte A, Hendlisz A, Sclafani F. Pretta A, et al. Among authors: deleporte a. Ann Oncol. 2020 Oct;31(10):1282-1284. doi: 10.1016/j.annonc.2020.07.006. Epub 2020 Jul 22. Ann Oncol. 2020. PMID: 32707167 Free article. No abstract available.
The confusion around neuroendocrine tumors.
Hendlisz A, Deleporte A. Hendlisz A, et al. Among authors: deleporte a. Curr Opin Oncol. 2012 Jul;24(4):431-2. doi: 10.1097/CCO.0b013e328352f67c. Curr Opin Oncol. 2012. PMID: 22476192 No abstract available.
PD-1 and PD-L1 inhibitors in oesophago-gastric cancers.
Akin Telli T, Bregni G, Camera S, Deleporte A, Hendlisz A, Sclafani F. Akin Telli T, et al. Among authors: deleporte a. Cancer Lett. 2020 Jan 28;469:142-150. doi: 10.1016/j.canlet.2019.10.036. Epub 2019 Oct 25. Cancer Lett. 2020. PMID: 31669518 Review.
Fat density is a novel prognostic marker in patients with esophageal cancer.
Anciaux M, Van Gossum A, Wenglinski C, Ameye L, Guiot T, Flamen P, Demetter P, Deleporte A, Sclafani F, Donckier V, Hendlisz A, Vandeputte C. Anciaux M, et al. Among authors: deleporte a. Clin Nutr ESPEN. 2020 Oct;39:124-130. doi: 10.1016/j.clnesp.2020.07.007. Epub 2020 Aug 11. Clin Nutr ESPEN. 2020. PMID: 32859305
MOMENTUM: A Phase I Trial Investigating 2 Schedules of Capecitabine With Aflibercept in Patients With Gastrointestinal and Breast Cancer.
Camera S, Deleporte A, Bregni G, Trevisi E, Pretta A, Telli TA, Polastro L, Gombos A, Kayumba A, Ameye L, Piccart-Gebhart M, Awada A, Sclafani F, Hendlisz A. Camera S, et al. Among authors: deleporte a. Clin Colorectal Cancer. 2020 Dec;19(4):311-318.e1. doi: 10.1016/j.clcc.2020.05.007. Epub 2020 May 29. Clin Colorectal Cancer. 2020. PMID: 32631787 Clinical Trial.
Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study.
Mileva M, Marin G, Levillain H, Artigas C, Van Bogaert C, Marin C, Danieli R, Deleporte A, Picchia S, Stathopoulos K, Jungels C, Vanderlinden B, Paesmans M, Ameye L, Critchi G, Taraji-Schiltz L, Velghe C, Wimana Z, Bali M, Hendlisz A, Flamen P, Karfis I. Mileva M, et al. Among authors: deleporte a. J Nucl Med. 2024 Feb 1;65(2):236-244. doi: 10.2967/jnumed.123.265987. J Nucl Med. 2024. PMID: 38164576 Clinical Trial.
42 results